SOAT1 and familial Alzheimer disease: Based on LINCS analysis predicting JAK/STAT inhibitors as top discordant perturbagens for reversing fAD-associated gene signatures (Fig. 3D), we performed a preliminary evaluation of baricitinib's effects in fAD astrocytes.